Peanut (Ara h 1) IgE Test · Blood

If you or your child has tested positive on a standard peanut allergy test but you're not sure whether that reflects a real allergy or harmless sensitization, component testing can sharpen the picture. This test looks at one specific protein inside the peanut, Ara h 1 (one of three major peanut storage proteins), rather than the whole peanut extract.

Standard peanut tests cast a wide net and catch many people whose bodies recognize peanut but never actually react to eating it. Component testing zooms in on the proteins most strongly tied to real allergic reactions. Ara h 1 is one of those proteins, though it is rarely the deciding piece on its own.

What This Test Actually Measures

This test measures IgE (immunoglobulin E) antibodies in your blood that target Ara h 1, a 7S seed storage protein found in peanut. IgE is the antibody class your immune system uses to mount allergic reactions. When peanut-specific IgE binds to immune cells called mast cells and basophils, eating peanut can trigger those cells to release the chemicals that cause hives, swelling, breathing trouble, or anaphylaxis.

Ara h 1 belongs to a family of three peanut storage proteins (Ara h 1, Ara h 2, and Ara h 3) that are strongly linked to genuine clinical peanut allergy. These proteins resist heat and digestion, so the body's IgE response to them tends to track real-world reactivity better than antibodies against more fragile peanut proteins.

Why Ara h 1 Matters in the Diagnostic Picture

On its own, Ara h 1 IgE is a supporting marker rather than a definitive answer. Across multiple pediatric studies, Ara h 2 IgE consistently outperformed Ara h 1 as a single test for diagnosing peanut allergy. But Ara h 1 still adds information, especially when combined with Ara h 2 and Ara h 3.

In Japanese children with challenge-confirmed peanut allergy, testing positive for all three storage proteins (Ara h 1, 2, and 3) together pushed specificity up to 94%, meaning very few people who tested positive on all three were actually tolerant. In a large US lab dataset, some children were positive for Ara h 1 or Ara h 3 but not Ara h 2, meaning Ara h 1 can catch a small group of genuinely sensitized people who would otherwise be missed.

How It Compares to Standard Peanut Testing

Standard skin prick tests and whole-peanut IgE blood tests are highly sensitive, meaning they almost always catch people who are allergic. The problem is specificity. Many people test positive on these tests without ever reacting to peanut. Component tests like Ara h 1 help separate true allergy from harmless sensitization.

Source: Riggioni et al., 2023 meta-analysis; Keet et al., 2021; Ebisawa et al., 2012; Valcour et al., 2017.

What this means for you: a positive Ara h 1 result is most informative when read alongside Ara h 2 and Ara h 3. If all three are positive, the case for true allergy is much stronger. If Ara h 1 is positive but Ara h 2 is not, the result is harder to interpret and usually requires more workup.

What Sensitization Pattern Reveals

Beyond simple yes-or-no diagnosis, the pattern of which peanut proteins your body recognizes can reveal something about how your peanut sensitization developed. In North American infants with early-onset peanut allergy, Ara h 1, 2, and 3 were the dominant targets, fitting the picture of classic, often persistent peanut allergy.

In contrast, in a study of peanut-sensitized adults from Southern China with allergic rhinitis or asthma, 21% had Ara h 1 IgE, but this often appeared alongside pollen sensitization, suggesting cross-reactivity with related plant proteins rather than dangerous primary peanut allergy. Reading Ara h 1 in context with other component tests helps distinguish these very different clinical pictures.

Tracking Ara h 1 Over Time

A single Ara h 1 measurement is a snapshot. Tracking it over time is far more informative, especially if your situation is changing. In children who naturally outgrow peanut allergy, levels of peanut and component-specific IgE generally decline over years while protective IgG4 antibodies rise. The trajectory of your numbers tells you more than any single reading.

During peanut oral immunotherapy (a treatment where small, gradually increasing doses of peanut are given under medical supervision), peanut and component IgE levels fell significantly. One study tracked patients for about 41 months and found median total peanut IgE dropped roughly 90%, from 85.45 to 7.75 kU/L. Component-level IgE to Ara h 1, 2, and 3 also contracted, while IgG4 antibodies (often considered protective) rose.

A practical cadence: get a baseline reading along with Ara h 2 and Ara h 3, retest in 3 to 6 months if you are pursuing immunotherapy or watching for natural resolution in a child, and at least annually thereafter to track the trend. A single elevated number is much less meaningful than a clear pattern over time.

What an Out-of-Pattern Result Should Make You Do

If Ara h 1 IgE is positive in isolation, especially without Ara h 2 positivity, the right next move is rarely panic or strict avoidance based on the number alone. Order Ara h 2 and Ara h 3 if you haven't already, since these together give the most reliable read on true allergy. A whole-peanut IgE and a skin prick test add another layer.

If component tests disagree with your history (you have eaten peanut without reacting, or you have reacted but tests look modest), see a board-certified allergist. An oral food challenge under medical supervision remains the most reliable way to settle ambiguous cases. Functional tests like the basophil activation test can also resolve discordant results in specialist settings.

For someone considering peanut oral immunotherapy, baseline Ara h 1, 2, and 3 plus total peanut IgE give a starting point. Tracking these during treatment, alongside IgG4 levels, helps your allergist judge whether the immune system is shifting toward tolerance.

When Results Can Be Misleading

• Sensitization is not allergy: a positive result can simply mean your immune system recognizes Ara h 1 without ever causing a reaction when you eat peanut. Many people with positive component tests tolerate peanut on a supervised oral challenge.
• A negative Ara h 1 result doesn't rule out peanut allergy: Ara h 2 is the stronger single marker, and even undetectable Ara h 2 or whole-peanut IgE does not absolutely exclude allergy if your history suggests reactions. Clinical context matters.
• Cross-reactivity with pollen proteins: in adults with pollen allergy, a positive Ara h 1 IgE can sometimes reflect immune recognition of related plant proteins rather than dangerous primary peanut allergy.
• Severity prediction is unreliable: expert guidelines explicitly caution against using component IgE levels to predict how severe a future reaction will be. A high number doesn't equal worse anaphylaxis risk, and a low number doesn't equal a mild reaction.

Resolving the Apparent Contradiction

It can feel paradoxical that Ara h 1 IgE has high specificity in some studies but low sensitivity, and that adding it to Ara h 2 doesn't always improve diagnosis. The framework that resolves this: Ara h 1 IgE is a pattern indicator, not a stand-alone diagnostic. It refines the picture when read alongside other components, but it doesn't capture every allergic patient on its own. A negative Ara h 1 in someone with positive Ara h 2 still strongly suggests allergy. A positive Ara h 1 in someone with negative Ara h 2 raises questions that usually need more workup, not certainty either way.